الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s001Testhttps://figshare.com/articles/figure/Image_1_CD4_T_Cells_of_Myasthenia_Gravis_Patients_Are_Characterized_by_Increased_IL-21_IL-4_and_IL-17A_Productions_and_Higher_Presence_of_PD-1_and_ICOS_JPEG/12324938Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s004Testhttps://figshare.com/articles/figure/Image_4_CD4_T_Cells_of_Myasthenia_Gravis_Patients_Are_Characterized_by_Increased_IL-21_IL-4_and_IL-17A_Productions_and_Higher_Presence_of_PD-1_and_ICOS_JPEG/12324956Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s003Testhttps://figshare.com/articles/figure/Image_3_CD4_T_Cells_of_Myasthenia_Gravis_Patients_Are_Characterized_by_Increased_IL-21_IL-4_and_IL-17A_Productions_and_Higher_Presence_of_PD-1_and_ICOS_JPEG/12324950Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s003Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s002Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s001Test
الإتاحة: https://doi.org/10.3389/fimmu.2020.00809.s004Test